Emerging research suggest Retatru tide , a dual activator targeting both the gut-brain axis and another hormone, may offer a notable development for obesity treatment. Initial patient trials have indicated substantial decreases in body fat , potentially exceeding existing body composition treatments. However , more assessment is required to complet